Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1743

1.

Does recall period matter? Comparing PROMIS® physical function with no recall, 24-hr recall, and 7-day recall.

Condon DM, Chapman R, Shaunfield S, Kallen MA, Beaumont JL, Eek D, Mitra D, Benjamin KL, McQuarrie K, Liu J, Shaw JW, Martin Nguyen A, Keating K, Cella D.

Qual Life Res. 2019 Nov 7. doi: 10.1007/s11136-019-02344-0. [Epub ahead of print]

PMID:
31701432
2.

Iron Insufficiency Diminishes the Erythropoietic Response to Moderate Altitude Exposure.

Okazaki K, Stray-Gundersen J, Chapman RF, Levine BD.

J Appl Physiol (1985). 2019 Oct 31. doi: 10.1152/japplphysiol.00115.2018. [Epub ahead of print]

PMID:
31670602
3.

Evaluating natural experiments to measure the co-benefits of urban policy interventions to reduce carbon emissions in New Zealand.

Howden-Chapman P, Keall M, Whitwell K, Chapman R.

Sci Total Environ. 2019 Oct 8;700:134408. doi: 10.1016/j.scitotenv.2019.134408. [Epub ahead of print]

PMID:
31627043
4.

Challenges in the use of corticosteroids in the management of autoimmune hepatitis.

Chapman RW, Aspinall RJ, Trivedi P, Wright G, Heneghan M.

Br J Hosp Med (Lond). 2019 Oct 2;80(10):594-599. doi: 10.12968/hmed.2019.80.10.594.

PMID:
31589514
5.

"Train-High Sleep-Low" Dietary Periodization Does Not Alter Ventilatory Strategies During Cycling Exercise.

Paris HL, Fulton TJ, Wilhite DP, Baranauskas MN, Chapman RF, Mickleborough TD.

J Am Coll Nutr. 2019 Sep 24:1-8. doi: 10.1080/07315724.2019.1654419. [Epub ahead of print]

PMID:
31549922
6.

Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States.

Carlson JJ, Walton SM, Basu A, Chapman RH, Campbell JD, McQueen RB, Pearson SD, Touchette DR, Veenstra D, Whittington MD, Ollendorf DA.

Pharmacoeconomics. 2019 Nov;37(11):1321-1327. doi: 10.1007/s40273-019-00832-2.

PMID:
31485925
7.

CiiiDER: A tool for predicting and analysing transcription factor binding sites.

Gearing LJ, Cumming HE, Chapman R, Finkel AM, Woodhouse IB, Luu K, Gould JA, Forster SC, Hertzog PJ.

PLoS One. 2019 Sep 4;14(9):e0215495. doi: 10.1371/journal.pone.0215495. eCollection 2019.

8.

State-Selective Dynamics of TiO2 Charge-Carrier Trapping and Recombination.

Zhang Y, Payne DT, Pang CL, Cacho C, Chapman RT, Springate E, Fielding HH, Thornton G.

J Phys Chem Lett. 2019 Aug 27:5265-5270. doi: 10.1021/acs.jpclett.9b02153. [Epub ahead of print]

PMID:
31434481
9.

Author Reply.

Zimmermann M, Lubinga SJ, Banken R, Rind D, Cramer G, Synnott PG, Chapman RH, Khan S, Carlson J.

Value Health. 2019 Aug;22(8):972-973. doi: 10.1016/j.jval.2019.03.009. Epub 2019 Jul 22. No abstract available.

PMID:
31426939
10.

United States Valuation of EQ-5D-5L Health States Using an International Protocol.

Pickard AS, Law EH, Jiang R, Pullenayegum E, Shaw JW, Xie F, Oppe M, Boye KS, Chapman RH, Gong CL, Balch A, Busschbach JJV.

Value Health. 2019 Aug;22(8):931-941. doi: 10.1016/j.jval.2019.02.009. Epub 2019 May 25.

11.

Preoperative Performance of the PROMIS in Patients Undergoing Hip Arthroscopic Surgery for Femoroacetabular Impingement Syndrome.

Nwachukwu BU, Beck EC, Chapman R, Chahla J, Okoroha K, Nho SJ.

Orthop J Sports Med. 2019 Jul 29;7(7):2325967119860079. doi: 10.1177/2325967119860079. eCollection 2019 Jul.

12.

Preclinical Development of U3-1784, a Novel FGFR4 Antibody Against Cancer, and Avoidance of Its On-target Toxicity.

Bartz R, Fukuchi K, Ohtsuka T, Lange T, Gruner K, Watanabe I, Hayashi S, Oda Y, Kawaida R, Komori H, Kashimoto Y, Wirtz P, Mayer JA, Redondo-Müller M, Saito S, Takahashi M, Hanzawa H, Imai E, Martinez A, Hanai M, Häussinger D, Chapman RW, Agatsuma T, Bange J, Abraham R.

Mol Cancer Ther. 2019 Oct;18(10):1832-1843. doi: 10.1158/1535-7163.MCT-18-0048. Epub 2019 Jul 26.

PMID:
31350344
13.

High coupling efficiency grating couplers on lithium niobate on insulator.

Krasnokutska I, Chapman RJ, Tambasco JJ, Peruzzo A.

Opt Express. 2019 Jun 24;27(13):17681-17685. doi: 10.1364/OE.27.017681.

PMID:
31252724
14.

Emissions from the road transport sector of New Zealand: key drivers and challenges.

Hasan MA, Frame DJ, Chapman R, Archie KM.

Environ Sci Pollut Res Int. 2019 Aug;26(23):23937-23957. doi: 10.1007/s11356-019-05734-6. Epub 2019 Jun 20.

PMID:
31222652
15.

Current Value Frameworks-What's New?

Willke RJ, Chapman RH, Seidman JJ, Schnipper LE, Gleason PP.

Value Health. 2019 Jun;22(6S):S7-S11. doi: 10.1016/j.jval.2019.04.1916. No abstract available.

PMID:
31200806
16.

Use of a Novel Enhanced DNA Vaccine Vector for Preclinical Virus Vaccine Investigation.

Chapman R, Rybicki EP.

Vaccines (Basel). 2019 Jun 13;7(2). pii: E50. doi: 10.3390/vaccines7020050. Review.

17.

New Cost-Effectiveness Methods to Determine Value-Based Prices for Potential Cures: What Are the Options?

Pearson SD, Ollendorf DA, Chapman RH.

Value Health. 2019 Jun;22(6):656-660. doi: 10.1016/j.jval.2019.01.012. Epub 2019 May 17.

PMID:
31198182
18.

The Adverse Impact of Unplanned Extubation in a Cohort of Critically Ill Neonates.

Kambestad KK, Huack A, Nair S, Chapman R, Chin S, Langga L, Mounger E, Guerrero E, Iyer NP.

Respir Care. 2019 May 28. pii: respcare.06721. doi: 10.4187/respcare.06721. [Epub ahead of print]

PMID:
31138734
19.

Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.

Lynch KD, Chapman RW, Keshav S, Montano-Loza AJ, Mason AL, Kremer AE, Vetter M, de Krijger M, Ponsioen CY, Trivedi P, Hirschfield G, Schramm C, Liu CH, Bowlus CL, Estes DJ, Pratt D, Hedin C, Bergquist A, de Vries AC, Janneke van der Woude C, Yu L, Assis DN, Boyer J, Ytting H, Hallibasic E, Trauner M, Marschall HU, Daretti LM, Marzioni M, Yimam KK, Perin N, Floreani A, Beretta-Piccoli BT, Rogers JK; International Primary Sclerosing Cholangitis Study Group (IPSCSG), Levy C.

Clin Gastroenterol Hepatol. 2019 May 14. pii: S1542-3565(19)30523-3. doi: 10.1016/j.cgh.2019.05.013. [Epub ahead of print]

20.

Photodissociation dynamics of CH3I probed via multiphoton ionisation photoelectron spectroscopy.

Warne EM, Downes-Ward B, Woodhouse J, Parkes MA, Bellshaw D, Springate E, Majchrzak P, Zhang Y, Karras G, Wyatt AS, Chapman RT, Kirrander A, Minns RS.

Phys Chem Chem Phys. 2019 Jun 7;21(21):11142-11149. doi: 10.1039/c9cp01477b. Epub 2019 May 16.

PMID:
31094379
21.

Comment on "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States".

McQueen RB, Whittington MD, Chapman RH, Kumar VM, Campbell JD.

Pharmacoeconomics. 2019 Jul;37(7):963-964. doi: 10.1007/s40273-019-00802-8. No abstract available.

PMID:
31044348
22.

Can We Develop Sustainable and Sharable Cost-Effectiveness Models for Value Assessment in the U.S. Health Care System?

Chapman RH, Kumar V.

J Manag Care Spec Pharm. 2019 May;25(5):521-524. doi: 10.18553/jmcp.2019.25.5.521.

23.

Screening duplex ultrasonography in neurosurgery patients does not correlate with a reduction in pulmonary embolism rate or decreased mortality.

Dickerson JC, Harriel KL, Dambrino RJ, Taylor LI, Rimes JA, Chapman RW, Desrosiers AS, Tullis JE, Washington CW.

J Neurosurg. 2019 Apr 26:1-9. doi: 10.3171/2018.12.JNS182800. [Epub ahead of print]

PMID:
31026839
24.

The Use of Biologics in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.

Lynch KD, Keshav S, Chapman RW.

Curr Hepatol Rep. 2019;18(1):115-126. doi: 10.1007/s11901-019-00456-2. Epub 2019 Mar 7. Review.

25.

Response to letter to the editor re 'The effect of inspiratory rise times on sputum movement during ventilator hyperinflation in a test lung model'.

Chapman RL.

Physiotherapy. 2019 Jun;105(2):295. doi: 10.1016/j.physio.2019.01.008. Epub 2019 Jan 22. No abstract available.

PMID:
31000367
26.

Impact of Abuse Deterrent Formulations of Opioids in Patients With Chronic Pain in the United States: A Cost-Effectiveness Model.

Kumar VM, Agboola F, Synnott PG, Segel C, Webb M, Ollendorf DA, Banken R, Chapman RH.

Value Health. 2019 Apr;22(4):416-422. doi: 10.1016/j.jval.2018.12.005. Epub 2019 Mar 21.

PMID:
30975392
27.

Continuously monitoring shoulder motion after total shoulder arthroplasty: maximum elevation and time spent above 90° of elevation are critical metrics to monitor.

Chapman RM, Torchia MT, Bell JE, Van Citters DW.

J Shoulder Elbow Surg. 2019 Aug;28(8):1505-1514. doi: 10.1016/j.jse.2019.01.003. Epub 2019 Apr 5.

PMID:
30956145
28.

Polymer mediated transport of the Hsp90 inhibitor LB76, a polar cyclic peptide, produces an Hsp90 cellular phenotype.

Rahimi MN, Foster HG, Farazi SN, Chapman R, McAlpine SR.

Chem Commun (Camb). 2019 Apr 11;55(31):4515-4518. doi: 10.1039/c9cc00890j.

PMID:
30920570
29.

Long-term Survival and Cost-effectiveness Associated With Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell Lymphoma.

Whittington MD, McQueen RB, Ollendorf DA, Kumar VM, Chapman RH, Tice JA, Pearson SD, Campbell JD.

JAMA Netw Open. 2019 Feb 1;2(2):e190035. doi: 10.1001/jamanetworkopen.2019.0035.

30.

Evolving role of magnetic resonance techniques in primary sclerosing cholangitis.

Selvaraj EA, Culver EL, Bungay H, Bailey A, Chapman RW, Pavlides M.

World J Gastroenterol. 2019 Feb 14;25(6):644-658. doi: 10.3748/wjg.v25.i6.644. Review.

31.

Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus.

van Diepen MT, Chapman R, Douglass N, Galant S, Moore PL, Margolin E, Ximba P, Morris L, Rybicki EP, Williamson AL.

J Virol. 2019 Apr 3;93(8). pii: e02155-18. doi: 10.1128/JVI.02155-18. Print 2019 Apr 15.

32.
33.

Cost Utility of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease.

Zimmermann M, Lubinga SJ, Banken R, Rind D, Cramer G, Synnott PG, Chapman RH, Khan S, Carlson J.

Value Health. 2019 Feb;22(2):161-167. doi: 10.1016/j.jval.2018.09.2841. Epub 2018 Oct 25.

PMID:
30711060
34.

Inspiratory Muscle Training: Improvement of Exercise Performance With Acute Hypoxic Exposure.

Hursh DG, Baranauskas MN, Wiggins CC, Bielko S, Mickleborough TD, Chapman RF.

Int J Sports Physiol Perform. 2019 Sep 1;14(8):1124-1131. doi: 10.1123/ijspp.2018-0483.

PMID:
30702370
35.

Special Environments: Altitude and Heat.

Saunders PU, Garvican-Lewis LA, Chapman RF, Périard JD.

Int J Sport Nutr Exerc Metab. 2019 Mar 1;29(2):210-219. doi: 10.1123/ijsnem.2018-0256. Epub 2019 Mar 12. Review.

PMID:
30676138
36.

A single dose of fluoxetine reduces neural limbic responses to anger in depressed adolescents.

Capitão LP, Chapman R, Murphy SE, Harvey CJ, James A, Cowen PJ, Harmer CJ.

Transl Psychiatry. 2019 Jan 21;9(1):30. doi: 10.1038/s41398-018-0332-2.

37.

The NHS long term plan and public health.

Chapman R, Middleton J.

BMJ. 2019 Jan 16;364:l218. doi: 10.1136/bmj.l218. No abstract available.

PMID:
30651224
38.

Stance and swing phase knee flexion recover at different rates following total knee arthroplasty: An inertial measurement unit study.

Chapman RM, Moschetti WE, Van Citters DW.

J Biomech. 2019 Feb 14;84:129-137. doi: 10.1016/j.jbiomech.2018.12.027. Epub 2018 Dec 31.

PMID:
30630627
39.

All Wrapped up: Stabilization of Enzymes within Single Enzyme Nanoparticles.

Chapman R, Stenzel MH.

J Am Chem Soc. 2019 Feb 20;141(7):2754-2769. doi: 10.1021/jacs.8b10338. Epub 2019 Feb 11.

PMID:
30621398
40.

Assessing Upper Extremity Biomechanics during Activities of Daily Living Using Inertial Measurement Units: Does our Concept of 'Normal' Apply?

Chapman R, Torchia M, Bell JE, Van Citters D.

J Biomech Eng. 2019 Jan 7. doi: 10.1115/1.4042433. [Epub ahead of print]

PMID:
30615037
41.

Ischemic Preconditioning, O2 Kinetics, and Performance in Normoxia and Hypoxia.

Wiggins CC, Constantini K, Paris HL, Mickleborough TD, Chapman RF.

Med Sci Sports Exerc. 2019 May;51(5):900-911. doi: 10.1249/MSS.0000000000001882.

PMID:
30601792
42.

Streptococcal dTDP-L-rhamnose biosynthesis enzymes: functional characterization and lead compound identification.

van der Beek SL, Zorzoli A, Çanak E, Chapman RN, Lucas K, Meyer BH, Evangelopoulos D, de Carvalho LPS, Boons GJ, Dorfmueller HC, van Sorge NM.

Mol Microbiol. 2019 Apr;111(4):951-964. doi: 10.1111/mmi.14197. Epub 2019 Jan 31.

43.

Convergent Evidence That ZNF804A Is a Regulator of Pre-messenger RNA Processing and Gene Expression.

Chapman RM, Tinsley CL, Hill MJ, Forrest MP, Tansey KE, Pardiñas AF, Rees E, Doyle AM, Wilkinson LS, Owen MJ, O'Donovan MC, Blake DJ.

Schizophr Bull. 2019 Oct 24;45(6):1267-1278. doi: 10.1093/schbul/sby183.

44.

Assessing the Value of Sarilumab Monotherapy for Adults with Moderately to Severely Active Rheumatoid Arthritis: A Cost-Effectiveness Analysis.

Whittington MD, McQueen RB, Ollendorf DA, Chapman RH, Kumar VM, Synnott PG, Agboola F, Campbell JD.

J Manag Care Spec Pharm. 2019 Jan;25(1):80-87. doi: 10.18553/jmcp.2019.25.1.080. Erratum in: J Manag Care Spec Pharm. 2019 Jun;25(6):726.

45.

Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System.

Goode EC, Clark AB, Mells GF, Srivastava B, Spiess K, Gelson WTH, Trivedi PJ, Lynch KD, Castren E, Vesterhus MN, Karlsen TH, Ji SG, Anderson CA, Thorburn D, Hudson M, Heneghan MA, Aldersley MA, Bathgate A, Sandford RN, Alexander GJ, Chapman RW, Walmsley M; UK-PSC Consortium, Hirschfield GM, Rushbrook SM.

Hepatology. 2019 May;69(5):2120-2135. doi: 10.1002/hep.30479. Epub 2019 Mar 4.

46.

Limitations of current in vitro models for testing the clinical potential of epigenetic inhibitors for treatment of pediatric ependymoma.

Rogers HA, Chapman R, Kings H, Allard J, Barron-Hastings J, Pajtler KW, Sill M, Pfister S, Grundy RG.

Oncotarget. 2018 Nov 23;9(92):36530-36541. doi: 10.18632/oncotarget.26370. eCollection 2018 Nov 23.

47.

The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256.

van Diepen MT, Chapman R, Moore PL, Margolin E, Hermanus T, Morris L, Ximba P, Rybicki EP, Williamson AL.

PLoS One. 2018 Dec 17;13(12):e0208310. doi: 10.1371/journal.pone.0208310. eCollection 2018.

48.

Higher offset cross-linked polyethylene acetabular liners: is wear a significant clinical concern?

Chapman RM, Van Citters DW, Chapman D, Dalury DF.

Hip Int. 2019 Nov;29(6):652-659. doi: 10.1177/1120700018815339. Epub 2018 Dec 7.

PMID:
30522361
49.

Cost-Effectiveness of Targeted Pharmacotherapy for Moderate to Severe Plaque Psoriasis.

Hendrix N, Ollendorf DA, Chapman RH, Loos A, Liu S, Kumar V, Linder JA, Pearson SD, Veenstra DL.

J Manag Care Spec Pharm. 2018 Dec;24(12):1210-1217. doi: 10.18553/jmcp.2018.24.12.1210.

50.

4,6- O-Pyruvyl Ketal Modified N-Acetylmannosamine of the Secondary Cell Wall Polysaccharide of Bacillus anthracis Is the Anchoring Residue for Its Surface Layer Proteins.

Chapman RN, Liu L, Boons GJ.

J Am Chem Soc. 2018 Dec 12;140(49):17079-17085. doi: 10.1021/jacs.8b08857. Epub 2018 Nov 30.

PMID:
30452253

Supplemental Content

Loading ...
Support Center